OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 2 filers reported holding OYSTER PT PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $34,000 | +112.5% | 2,997 | -2.7% | 0.00% | – |
| Q3 2022 | $16,000 | +33.3% | 3,079 | +2.7% | 0.00% | – |
| Q2 2022 | $12,000 | -71.4% | 2,997 | -18.5% | 0.00% | – |
| Q1 2022 | $42,000 | -55.8% | 3,679 | -29.7% | 0.00% | – |
| Q4 2021 | $95,000 | +72.7% | 5,232 | +12.5% | 0.00% | – |
| Q3 2021 | $55,000 | +77.4% | 4,651 | +162.9% | 0.00% | – |
| Q2 2021 | $31,000 | +14.8% | 1,769 | +22.7% | 0.00% | – |
| Q1 2021 | $27,000 | +22.7% | 1,442 | +25.0% | 0.00% | – |
| Q4 2020 | $22,000 | +4.8% | 1,154 | +14.0% | 0.00% | – |
| Q3 2020 | $21,000 | -19.2% | 1,012 | +10.4% | 0.00% | – |
| Q2 2020 | $26,000 | +2500.0% | 917 | +2858.1% | 0.00% | – |
| Q1 2020 | $1,000 | -93.8% | 31 | -95.2% | 0.00% | – |
| Q4 2019 | $16,000 | – | 645 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
| Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
| NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
| KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
| Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
| COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
| RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
| Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |